Oracle's Credit Insurance Hits October Highs as AI Selloff Meets a Funding Rebuttal
Published on 11/21/2026 at 13:41 | Editorial boerse-global.deOracle's stock bore the brunt of a broad AI-linked selloff yesterday, sliding 8.6% to close at €92.06 — a level just 0.7% above its 52-week low. The drop came as AP reported mounting concerns over whether the sector's heavy AI spending and the pace of data-center construction can be sustained. The retreat in AI names followed Anthropic's initial public offering.
The equity move was not the only pressure point. According to Bloomberg, the cost of insuring Oracle's debt against default over five years climbed to its highest level since October 20, part of a wider repricing of credit risk across the technology sector.
Funding Package Complete, Company Says
Oracle pushed back against the anxiety after the selloff, confirming that financing for its infrastructure contract with OpenAI is fully in place. The company said the arrangement includes supplier financing, and that the last capital raise was completed in early November. The package unveiled at its October investor day is now assembled in full, and Oracle stated that no further talks with suppliers are needed to fulfill the contract. Reports suggesting otherwise were rejected in the same statement.
Alongside that assurance, Oracle reaffirmed its cash-flow targets: free cash flow is set to turn positive in the second half of fiscal 2028 and to exceed $30 billion in fiscal 2029. From that point, the company intends to fund further growth from its own resources.
Should investors sell immediately? Or is it worth buying Oracle?
Plan and Issuance Line Up Almost Exactly
The capital-markets piece of the puzzle can be checked against the plan. At the investor day, Oracle penciled in $20 billion of additional capital for the fiscal 2027–2030 investment cycle — $10 billion from new equity and $10 billion from new debt. On November 2, it priced a package of precisely that shape: roughly $10 billion in shares and roughly $10 billion in bonds, for about $20 billion gross. Plan and issuance match almost one for one.
The fit is not perfect. After costs, the equity brings in about $9.9 billion and the bonds about $10.0 billion, leaving net proceeds a shade below the target. The debt also carries a price: coupons of between 7% and 8.65% a year, with maturities running from 2029 to 2046. Those interest payments fall due long before free cash flow is projected to turn positive.
The comparison also covers only this one building block. For supplier financing, Oracle's own statement is the source, and the cash-flow targets are company forecasts.
Execution Is the Real Test
Whether those forecasts land depends on construction. At the end of August, Oracle carried $664 billion in committed but undelivered performance obligations across the group. Roughly half is expected to be recognized as revenue within 36 months — 13% in the first twelve months and 37% across the two years after that. Those figures reflect expected revenue for the entire company, not just the OpenAI contract.
Oracle at a turning point? This analysis reveals what investors need to know now.
On that front, Oracle reports progress: the Abilene campus is nearly complete and the next major site, Shackelford, is fully permitted. Delivery of new NVIDIA racks is on schedule for the coming weeks. At the same time, chief executive Clay Magouyrk warned at the November 18 shareholder meeting that memory chips will become the biggest bottleneck for AI data centers in the years ahead.
The capital component Oracle set out to raise has been gathered at the intended size, and the company declares the entire package for the OpenAI buildout secured. No funding gap has been substantiated. The principal risk sits in execution: capacity must be built, equipped and handed over on time.
Ad
Oracle Stock: New Analysis - 21 November
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
